As a leading provider of diabetes care systems, Bionime is committed to R&D and production. Our products are designed to provide accurate and trustworthy blood glucose monitoring.


All products are independently developed and manufactured by Bionime, spanning 80 technological fields with over 380 global patents. The entire manufacturing process is self-controlled, encompassing all key technologies, to ensure product quality.


Bionime follows the Six Sigma management model to enforce strict quality and production control. The products undergo multiple rigorous certifications worldwide, including Taiwan GMP, CE certification, and ISO13485…etc. Through the most rigorous quality control and testing, every medical diagnostic product leaving the factory is ensured to provide peace of mind for Patients with Diabetes (PWDs) when in use.


Bionime is thrilled to explore new opportunities for collaboration with you at the event! Let’s connect and see how we can work together to make a positive impact.
See you at ATTD 2024!


The following are the models showcased in our booth:
iFree 2 CGM、GM700SB、GM700Pro 2、Max Dual、Max Tel、GM280B、GM260、GM550


Connect with us at Bionime Corporation, and on LinkedIn at https://www.linkedin.com/company/bionime